Zydus buys Assertio (ASRT); EVP Schlessinger equity cashed out at $23.50
Rhea-AI Filing Summary
Assertio Holdings, Inc. executive vice president and general counsel Sam Schlessinger reported the cash-out of his equity in connection with the company’s merger with Zydus Worldwide DMCC. A Zydus subsidiary completed a tender offer for all Assertio common shares at $23.50 per share in cash, followed by a merger that made Assertio a wholly owned subsidiary.
Schlessinger disposed of 14,738 shares of common stock pursuant to the tender offer and merger. He also disposed of stock options covering 21,128 shares at an exercise price of $11.77, 12,591 shares at $12.177, and 18,900 shares at $11.8965, as well as 25,748 restricted stock units, all converted into cash or cancelled under the merger agreement mechanics. Following these transactions, his reported holdings in these instruments were reduced to zero.
Positive
- None.
Negative
- None.
Insights
Executive equity fully cashed out in Assertio’s sale to Zydus.
The filing shows Sam Schlessinger, EVP and general counsel of Assertio, disposing of all reported equity interests as part of the company’s merger with Zydus Worldwide DMCC. Common shares were bought in a tender offer at $23.50 per share, then the company was merged into a Zydus subsidiary.
Equity awards were treated mechanically under the merger agreement. Vested and unvested restricted stock units and in-the-money stock options were cancelled and converted into cash based on the same $23.50 offer price, while higher-priced options were cancelled without payment. This is standard treatment in many cash acquisitions.
Because all reported holdings fall to zero, this is a complete exit for this insider, driven by the change-of-control transaction rather than open-market trading. The economic outcome for shareholders and insiders is defined by the agreed cash price and the merger terms already disclosed in earlier deal documents.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Restricted Stock Units | 25,748 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 15,666 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 18,900 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 12,591 | $0.00 | -- |
| Disposition | Stock Option (Right to Buy) | 21,128 | $0.00 | -- |
| U | Common Stock | 14,738 | $0.00 | -- |
Footnotes (1)
- This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 13, 2026, by and among Assertio Holdings, Inc. (the "Issuer"), Zydus Worldwide DMCC ("Parent"), Zara Merger Sub Inc., a wholly owned subsidiary of Parent ("Purchaser") and Zydus Pharmaceuticals (USA) Inc., pursuant to which Purchaser completed a tender offer (the "Offer") for all outstanding shares of common stock of the Issuer ("Company Common Stock") at a price of $23.50 per share in cash, without interest (the "Offer Price"), and thereafter merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent (the "Merger"), effective as of June 16, 2026 (the "Effective Time"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right [continues to Footnote 2] [continues from Footnote 1] to receive the Offer Price, less any applicable withholding taxes. Pursuant to the Merger Agreement, each restricted stock unit of the Issuer (each, a "Company RSU") that was outstanding but unvested immediately prior to the Effective Time became fully vested as of immediately prior to the Effective Time and, at the Effective Time, each outstanding Company RSU was cancelled and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the Offer Price. Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock (each, a "Company Stock Option") that was outstanding immediately prior to the Effective Time, whether vested or unvested, with an exercise price per share less than the Offer Price, was cancelled at the Effective Time and converted into the right to receive a cash payment, less any applicable withholding taxes, equal to the product of (A) the excess of the Offer Price over the exercise price payable per share of Company Common Stock under such Company Stock Option, multiplied by (B) the total number of shares of Company Common Stock subject to such Company Stock Option. Each Company Stock Option with an exercise price per share equal to or greater than the Offer Price was cancelled at the Effective Time without any cash payment in respect thereof.